human albumin and propofol

PreclinicalSmall molecule

UUniversity of California, San Diego

human albumin and propofol is one of 7 small molecule programs targeting Propofol. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PropofolCompleted

PropofolPreclinical

Completed

Competition

Competitive Landscape

8 competitors in Propofol

#DrugCompanyPhaseTrials

Amidate

Pfizer

Approved

2 2

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

1 3

Alfenta

Jazz Pharmaceuticals

Preclinical

1 4

Xylocaine

MMEDRx USA, Inc.

Preclinical

3 5

Esmeron

FFresenius Kabi USA, LLC

Preclinical

1 6

N,N-Dimethyltryptamine

AAlgernon Pharmaceuticals

Preclinical

1 7

human albumin and propofol

UUniversity of California, San Diego

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Propofol1 trial

Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations

Completed·UUniversity of California, San Diego·N/A·NCT02613052·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for human albumin and propofol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — human albumin and propofol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for human albumin and propofol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, San Diego company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of California, San Diego

human albumin and propofol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Propofol1 trial

References

Drug Info

Quick Facts

Related News